AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 SEP 26 - (NewsRx.com & NewsRx.net) -- Wyeth Pharmaceuticals of Madison, New Jersey, is announcing that patients who have received the Norplant System and who were using backup contraception may safely stop using backup methods for contraception.
Previously, patients had been advised to use backup contraception due to concerns about lower-than-expected release of the hormone levonorgestrel from several specific lots. Wyeth also announced that it does not plan to resume distribution or marketing of the 6-capsule Norplant System (levonorgestrel implants), which provides contraception for 5 years.
Wyeth issued letters on July 26, 2002 to health care professionals and patients, advising patients who have Norplant System capsules from specified lots that backup contraception may safely be discontinued. The company also notified health care professionals that testing of the specified lots has not shown the effectiveness of the Norplant implants to be different from that seen in the clinical trials and product labeling.
This information follows two alerts issued by Wyeth in September and October 2000 that advised doctors to discontinue insertion of Norplant system from lots ...